Reimbursement of licensed cell and gene therapies across the major European healthcare markets
Author:
Affiliation:
1. Cell Therapy Catapult Limited, Guys Hospital, London, UK
Publisher
Informa UK Limited
Link
https://www.tandfonline.com/doi/pdf/10.3402/jmahp.v3.29321
Reference1 articles.
1. Legifrance, Décret n° 2012-1116 du 2 octobre 2012 relatif aux missions médico-économiques de la Haute Autorité de santé. 2012
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Illustrating the Financial Consequences of Outcome-Based Payment Models From a Payers Perspective: The Case of Autologous Gene Therapy Atidarsagene Autotemcel (Libmeldy®);Value in Health;2024-08
2. Paving the way for future gene therapies: A case study of scientific spillover from delandistrogene moxeparvovec;Molecular Therapy - Methods & Clinical Development;2023-09
3. Financing and Reimbursement of Approved Advanced Therapies in Several European Countries;Value in Health;2023-06
4. “I just wanted to speak to someone- and there was no one…”: using Burden of Treatment Theory to understand the impact of a novel ATMP on early recipients;Orphanet Journal of Rare Diseases;2023-04-17
5. When Reality Does Not Meet Expectations—Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs;International Journal of Environmental Research and Public Health;2022-12-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3